Luc Rakotoarisoa

Strasbourg, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial.

Postprandial ultra-fast insulin versus mealtime fast-acting insulin in adults with cystic fibrosis-related diabetes: A randomized multicentre crossover trial.

Journal: Diabetes research and clinical practice
Published: August 05, 2026

NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation.

NKX6.1 mRNA copy number is an actionable biomarker associated with islet function and clinical outcomes after islet transplantation.

Journal: Science translational medicine
Published: March 25, 2026

Comparative accuracy of smartphone apps and a generative AI tool for carbohydrate counting: An independent bicentric study.

Comparative accuracy of smartphone apps and a generative AI tool for carbohydrate counting: An independent bicentric study.

Journal: Diabetes, obesity & metabolism
Published: November 02, 2025

Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.

Continuous glucose monitoring is a better indicator of glucose tolerance than HbA1c in cystic fibrosis.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: August 24, 2025

Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study.

Hypoglycemia incidence and behavioural adjustments during free-living unstructured physical activity in adults with type 1 diabetes using AID systems: Results from the RAPPID study.

Journal: Diabetes, obesity & metabolism
Published: July 20, 2025

Study of Insulin Treatment Modalities in Adults With Cystic Fibrosis-Related Diabetes After Elexacaftor-Tezacaftor-Ivacaftor Therapy.

Study of Insulin Treatment Modalities in Adults With Cystic Fibrosis-Related Diabetes After Elexacaftor-Tezacaftor-Ivacaftor Therapy.

Journal: Clinical therapeutics
Published: June 02, 2025

Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes.

Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes.

Journal: Diabetes & metabolism
Published: March 26, 2025

Impact of Islet Transplantation on Diabetes Complications and Mortality in Patients Living With Type 1 Diabetes.

Impact of Islet Transplantation on Diabetes Complications and Mortality in Patients Living With Type 1 Diabetes.

Journal: Diabetes care
Published: January 08, 2025

MiniMedTM 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes.

MiniMedTM 780G Advanced Hybrid Closed-Loop System Study in Pregnant Women with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics
Published: November 13, 2023

Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department.

Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department.

Journal: Diabetes & metabolism
Published: June 28, 2023

Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.

Early glucose abnormalities revealed by continuous glucose monitoring associate with lung function decline in cystic fibrosis: A five-year prospective study.

Journal: Journal of diabetes and its complications
Published: May 03, 2023

Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis.

Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis.

Journal: Diabetes & metabolism
Published: January 11, 2023
Showing 1-12 of 14

Last Updated: 09/26/2026